Abstract
The recent application of monoclonal antibody stains to Mohs micrographic surgery may lead to increased accuracy in the excision of certain difficult tumours. Immunohistochemical techniques may also increase the range of tumours regularly treated by Mohs surgery. The concept is very much in its infancy, and controlled trials with long-term follow-up are required before the real worth of the process can be evaluated.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
